aTyr Pharma Inc (LIFE.OQ)
LIFE.OQ on NASDAQ Stock Exchange Global Select Market
0.83USD
4:00pm EDT
0.83USD
4:00pm EDT
Change (% chg)
$0.05 (+5.85%)
$0.05 (+5.85%)
Prev Close
$0.79
$0.79
Open
$0.80
$0.80
Day's High
$0.88
$0.88
Day's Low
$0.80
$0.80
Volume
58,461
58,461
Avg. Vol
106,895
106,895
52-wk High
$6.45
$6.45
52-wk Low
$0.60
$0.60
About
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)
Overall
| Beta: | 3.00 |
| Market Cap(Mil.): | $23.44 |
| Shares Outstanding(Mil.): | 29.86 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| LIFE.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 109.17 | 32.55 |
| EPS (TTM): | -1.53 | -- | -- |
| ROI: | -80.23 | 1.47 | 12.80 |
| ROE: | -102.44 | 0.22 | 14.92 |
BRIEF-Atyr Pharma Inc Posts Qtrly Loss Of $0.36 Per Share
* ATYR PHARMA ANNOUNCES FIRST QUARTER 2018 OPERATING RESULTS, PROGRAM PRIORITIZATION AND CORPORATE RESTRUCTURING
Estimates